
Hikal Limited – NSE:HIKAL.NS
Hikal Limited stock price today
Hikal Limited stock price monthly change
Hikal Limited stock price quarterly change
Hikal Limited stock price yearly change
Hikal Limited key metrics
Market Cap | 45.16B |
Enterprise value | 54.58B |
P/E | 64.16 |
EV/Sales | 3.00 |
EV/EBITDA | 18.59 |
Price/Sales | 2.58 |
Price/Book | 3.91 |
PEG ratio | 2.31 |
EPS | 5.65 |
Revenue | 17.79B |
EBITDA | 2.68B |
Income | 696M |
Revenue Q/Q | -4.42% |
Revenue Y/Y | -11.25% |
Profit margin | 4.04% |
Oper. margin | 6.82% |
Gross margin | 38.96% |
EBIT margin | 6.82% |
EBITDA margin | 15.12% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHikal Limited stock price history
Hikal Limited stock forecast
Hikal Limited financial statements
Jun 2023 | 3.86B | 69.2M | 1.79% |
---|---|---|---|
Sep 2023 | 4.31B | 125.7M | 2.91% |
Dec 2023 | 4.47B | 161.4M | 3.61% |
Mar 2024 | 5.14B | 339.7M | 6.61% |
2026 | 22.95B | 1.70B | 7.45% |
---|
Analysts Price target
Financials & Ratios estimates
Payout ratio | 0% |
---|
2016 | 1.03% |
---|---|
2017 | 0.9% |
2019 | 0.73% |
2020 | 2.77% |
2022 | 0.55% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 23908500000 | 12.45B | 52.1% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 24871400000 | 12.99B | 52.25% |
Jun 2023 | 554.6M | 0 | 0 |
---|---|---|---|
Sep 2023 | 571.4M | 0 | 0 |
Dec 2023 | 579.4M | 0 | 0 |
Mar 2024 | 0 | 0 | 0 |
Hikal Limited alternative data
Aug 2023 | 1,906 |
---|---|
Sep 2023 | 1,906 |
Oct 2023 | 2,142 |
Nov 2023 | 2,142 |
Dec 2023 | 2,142 |
Jan 2024 | 2,142 |
Feb 2024 | 2,142 |
Mar 2024 | 2,142 |
Apr 2024 | 2,142 |
May 2024 | 2,142 |
Jun 2024 | 2,142 |
Jul 2024 | 2,142 |
Hikal Limited other data
Insider | Compensation |
---|---|
Mr. Sameer Hiremath (1974) MD & Director | $45,530,000 |
-
What's the price of Hikal Limited stock today?
One share of Hikal Limited stock can currently be purchased for approximately $530.
-
When is Hikal Limited's next earnings date?
Unfortunately, Hikal Limited's (HIKAL.NS) next earnings date is currently unknown.
-
Does Hikal Limited pay dividends?
Yes, Hikal Limited pays dividends and its trailing 12-month yield is 0.31% with 0% payout ratio. The last Hikal Limited stock dividend of $0 was paid on 5 Sep 2025.
-
How much money does Hikal Limited make?
Hikal Limited has a market capitalization of 45.16B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 7.34% to 17.85B US dollars.
-
What is Hikal Limited's stock symbol?
Hikal Limited is traded on the NSE under the ticker symbol "HIKAL.NS".
-
What is Hikal Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Hikal Limited?
Shares of Hikal Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Hikal Limited's key executives?
Hikal Limited's management team includes the following people:
- Mr. Sameer Hiremath MD & Director(age: 51, pay: $45,530,000)
-
How many employees does Hikal Limited have?
As Jul 2024, Hikal Limited employs 2,142 workers.
-
When Hikal Limited went public?
Hikal Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.
-
What is Hikal Limited's official website?
The official website for Hikal Limited is hikal.com.
-
How can i contact Hikal Limited?
Hikal Limited can be reached via phone at +91 22 3097 3100.
Hikal Limited company profile:

Hikal Limited
hikal.comNSE
2,061
Drug Manufacturers - Specialty & Generic
Healthcare
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Navi Mumbai, 400614
:
ISIN: INE475B01022
CUSIP: Y3195T157